Target intelligence / Profile preview

Myosin-Ie (MYO1E)

Target
MYO1E
Molecular classification
Motor protein, Actin-binding protein, Unconventional myosin, Molecular motor, Cytoskeletal protein
01

Overview

Myosin-Ie (MYO1E) is a nonmuscle class I myosin protein that acts as an ATP-dependent actin-based molecular motor, critical for intracellular movement, membrane trafficking, and the organization of the cytoskeleton[1][3][5][6]. It is characterized by a long “tail” with SH3 and Pleckstrin Homology (PH) domains, which allow it to bind lipids and interact with multiple proteins[1][2][3][5]. MYO1E is essential for the structure and function of kidney podocyte cells, where it maintains the glomerular filtration barrier; mutations in MYO1E cause inherited forms of nephrotic syndrome and focal segmental glomerulosclerosis[1][3][7]. In mammalian cells, MYO1E is involved in clathrin-mediated endocytosis, trafficking of clathrin-coated vesicles, and rapid rearrangement of actin filaments[2][3]. Overexpression or mutation of MYO1E is implicated in cancer progression (notably lung adenocarcinoma and basal-like breast cancer) and kidney diseases, linking MYO1E to both cytoskeletal integrity and disease pathogenesis[1][3][7][5].

Other names
Myosin 1EHuncM-ICFSGS6unconventional myosin-Iemyosin-ICMYO1E variant proteinmyr3 (rat ortholog)
02

Biological functions

Actin-based intracellular transportMembrane traffickingCytoskeletal organizationEndocytosis (especially clathrin-mediated endocytosis)Maintenance of glomerular filtration barrier integrityCell migration and motility
03

Disease associations

Focal segmental glomerulosclerosis (FSGS)Hereditary steroid-resistant nephrotic syndromeCancer (e.g., negative prognosis in lung adenocarcinoma, basal-like breast cancer)
04

Biomarkers

Overexpression in certain cancers (e.g., lung adenocarcinoma—adverse prognosis)genotype in familial FSGS

Beyond the preview

Go deeper on Myosin-Ie (MYO1E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin-Ie (MYO1E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call